MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-10-2026
Sonoma Pharmaceuticals Shares 2011-2026 | SNOA
Annual Shares Sonoma Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.24 M | 455 K | 3.39 M | 2.65 K | 2 M | 1.48 M | 924 K | 503 K | 474 K | 365 K | 215 K | 153 K | 111 K | 86.9 K | 83.7 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.39 M | 2.65 K | 765 K |
Quarterly Shares Sonoma Pharmaceuticals
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.71 M | 1.65 M | 1.64 M | 1.63 M | 1.46 M | 1.03 M | 851 K | 780 K | 546 K | 258 K | 4.94 M | 4.93 M | 3.11 M | 3.1 K | 3.1 K | 3.1 M | 3.08 K | 2.51 K | 2.22 K | 2.09 M | 2.05 K | 2.01 M | 2.01 M | 1.84 M | 1.5 M | 1.32 M | 1.32 M | 1.32 M | 971 K | 8.74 M | 693 K | 686 K | 4.39 M | 4.31 M | 4.29 M | 4.29 M | 4.22 M | 4.21 M | 4.2 M | 4.2 M | 3.29 M | 3.2 M | 3.14 M | 15 M | 8.6 M | 8.49 M | 8.42 M | 8.16 M | 6.81 K | 6.69 K | 6.62 K | 6.58 M | 5.13 M | 4.77 M | 4.59 K | 4.14 M | 27 M | 26.9 K | 26.8 K | 26.6 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 27 M | 2.05 K | 3.65 M |
Shares of other stocks in the Drug manufacturers industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
25.8 M | - | 7.5 % | $ 6.35 M |  USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
150 M | - | 0.86 % | $ 117 M | USA |
 |
Canopy Growth Corporation
CGC
|
108 M | $ 1.07 | -0.47 % | $ 115 M |  Canada |
 |
Aerie Pharmaceuticals
AERI
|
46.3 M | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
2.16 M | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
25.6 M | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
350 M | $ 2.62 | -0.57 % | $ 1.36 B | Canada |
 |
Avadel Pharmaceuticals plc
AVDL
|
95.1 M | - | - | $ 2.06 B |  France |
 |
China Pharma Holdings
CPHI
|
17.5 M | $ 0.55 | -0.97 % | $ 9.61 M |  China |
 |
Cumberland Pharmaceuticals
CPIX
|
14.1 M | $ 4.5 | -7.02 % | $ 63.3 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
50.8 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
127 M | - | 2.45 % | $ 38.1 M | Canada |
 |
Aurora Cannabis
ACB
|
169 M | $ 3.52 | -5.26 % | $ 86.3 M | Canada |
 |
Athenex
ATNX
|
6.54 M | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
36.8 M | $ 38.95 | -27.32 % | $ 1.43 B | USA |
 |
Emergent BioSolutions
EBS
|
51.2 M | $ 8.87 | -1.33 % | $ 454 M | USA |
 |
Assertio Holdings
ASRT
|
71 M | $ 11.92 | 1.24 % | $ 847 M | USA |
 |
Evolus
EOLS
|
62 M | $ 4.21 | -1.86 % | $ 261 M | USA |
 |
Bausch Health Companies
BHC
|
365 M | $ 5.77 | -3.11 % | $ 2.11 B | Canada |
 |
Lannett Company
LCI
|
40.4 M | - | 1.15 % | $ 7.11 M | USA |
 |
Catalent
CTLT
|
181 M | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
26.3 M | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
12.9 M | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
235 M | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
3.34 M | - | - | $ 36.6 M | USA |
 |
OrganiGram Holdings
OGI
|
256 M | $ 1.38 | -3.17 % | $ 402 M | Canada |
 |
Organogenesis Holdings
ORGO
|
132 M | $ 2.86 | -4.67 % | $ 377 M | USA |
 |
Perrigo Company plc
PRGO
|
138 M | $ 11.38 | -7.97 % | $ 1.58 B | USA |
 |
Rockwell Medical
RMTI
|
23.3 M | $ 0.9 | 0.37 % | $ 21 M | USA |
 |
Jupiter Wellness
JUPW
|
54.4 M | - | - | $ 33.6 M | USA |
 |
Sundial Growers
SNDL
|
1.86 M | $ 1.53 | 0.33 % | $ 3.37 M | Canada |
 |
Neoleukin Therapeutics
NLTX
|
492 K | - | - | $ 193 M | Canada |
 |
TherapeuticsMD
TXMD
|
10.4 M | $ 2.26 | 1.0 % | $ 23.6 M | USA |
 |
Pacira BioSciences
PCRX
|
46.2 M | $ 22.06 | 3.67 % | $ 1.02 B | USA |
 |
Veru
VERU
|
135 M | $ 2.54 | -3.05 % | $ 343 M | USA |
 |
PetIQ
PETQ
|
29.1 M | - | 1.64 % | $ 400 M | USA |
 |
OptiNose
OPTN
|
112 M | - | - | $ 1.08 B | USA |
 |
ProPhase Labs
PRPH
|
15.8 M | - | - | $ 5.07 M | USA |
 |
Viatris
VTRS
|
1.2 B | $ 15.09 | -3.89 % | $ 18.1 B | USA |
 |
PLx Pharma
PLXP
|
23.7 M | - | -27.8 % | $ 2.56 M | USA |
 |
Radius Health
RDUS
|
47.2 M | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
95.2 M | - | -4.76 % | $ 65.3 M | USA |
 |
Relmada Therapeutics
RLMD
|
30.1 M | $ 4.67 | -3.51 % | $ 141 M | USA |
 |
cbdMD
YCBD
|
4.31 M | $ 0.79 | -2.48 % | $ 3.41 M | USA |
 |
SCYNEXIS
SCYX
|
47.9 M | $ 0.73 | -2.19 % | $ 34.9 M | USA |
 |
Solid Biosciences
SLDB
|
40.8 M | $ 5.99 | -3.47 % | $ 244 M | USA |
 |
Tricida
TCDA
|
51.3 M | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
618 M | $ 7.37 | -2.97 % | $ 4.55 B | Canada |
 |
Zynerba Pharmaceuticals
ZYNE
|
42.7 M | - | - | $ 55.5 M | USA |